Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Surface Oncology Inc (SURF)

Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,082
  • Shares Outstanding, K 60,824
  • Annual Sales, $ 30,000 K
  • Annual Income, $ -63,590 K
  • 60-Month Beta 1.75
  • Price/Sales 2.19
  • Price/Cash Flow N/A
  • Price/Book 1.32
Trade SURF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.48
  • Most Recent Earnings $-0.41 on 08/02/23
  • Latest Earnings Date 11/01/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.36
  • Number of Estimates 3
  • High Estimate -0.34
  • Low Estimate -0.38
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8270 +29.38%
on 08/18/23
1.1200 -4.46%
on 09/01/23
+0.0844 (+8.56%)
since 08/07/23
3-Month
0.7124 +50.20%
on 06/15/23
1.1200 -4.46%
on 09/01/23
+0.3025 (+39.41%)
since 06/07/23
52-Week
0.5550 +92.79%
on 04/28/23
1.4300 -25.17%
on 11/01/22
-0.2500 (-18.94%)
since 09/07/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BG, SURF, KLR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BG : 103.01 (+0.58%)
SURF : 1.0700 (-0.93%)
KLR : 7.24 (-0.14%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEX, TALS, QUOT, SURF

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEX : 10.61 (+0.95%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SURF : 1.0700 (-0.93%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SURF, RETA, INPX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SURF : 1.0700 (-0.93%)
RETA : 172.36 (+0.02%)
INPX : 0.0527 (-11.13%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALS : 27.20 (-0.73%)
SURF : 1.0700 (-0.93%)
NEX : 10.61 (+0.95%)
CIR : 56.00 (+5.16%)
Moore Kuehn Encourages SURF, NEX, NETI, and DICE Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

SURF : 1.0700 (-0.93%)
NEX : 10.61 (+0.95%)
NETI : 11.33 (+0.09%)
DICE : 47.55 (+0.06%)
Shareholder Alert: Ademi LLP investigates whether Surface Oncology, Inc. has obtained a Fair Price in its transaction with Coherus

/PRNewswire/ -- Ademi LLP is investigating Surface (Nasdaq: SURF) for possible breaches of fiduciary duty and other violations of law in its transaction with...

SURF : 1.0700 (-0.93%)
Walgreens (WBA) to Report Q2 Earnings: What's in the Cards?

Walgreens' (WBA) strategic executions on the United States and the international front is likely to have contributed to the Q2 2023 top line.

ICLR : 333.37 (+1.17%)
WBA : 21.30 (+1.33%)
LNTH : 61.59 (+1.87%)
SURF : 1.0700 (-0.93%)
Lantheus Holdings (LNTH) Q4 Earnings and Revenues Surpass Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 42.71% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 61.59 (+1.87%)
SURF : 1.0700 (-0.93%)
Envista (NVST) Surpasses Q4 Earnings and Revenue Estimates

Envista (NVST) delivered earnings and revenue surprises of 6.12% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

NVST : 21.48 (-0.32%)
SURF : 1.0700 (-0.93%)
TG Therapeutics (TGTX) Soars 8.7%: Is Further Upside Left in the Stock?

TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

TGTX : 15.44 (-0.83%)
SURF : 1.0700 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 1.1833
2nd Resistance Point 1.1367
1st Resistance Point 1.1033
Last Price 1.0700
1st Support Level 1.0233
2nd Support Level 0.9767
3rd Support Level 0.9433

See More

52-Week High 1.4300
Fibonacci 61.8% 1.0957
Last Price 1.0700
Fibonacci 50% 0.9925
Fibonacci 38.2% 0.8892
52-Week Low 0.5550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar